Commercial crude stocks are seen down by 1.1 million barrels to 419.9 million barrels in the week ended Dec. 20, according to the average estimate of seven analysts and traders. Five expect a fall and ...

U.S. mortgage rates jumped to the highest level in five months as the year drew to a close. In the last full week of 2024, ...

Gas in underground storage is expected to have fallen by 97 billion cubic feet to 3,525 Bcf in the week ended Dec. 20, according to the average estimate of nine analysts, brokers and traders.

Quantum-computing stocks were back in rally mode on Thursday. Shares of Rigetti Computing Inc. were up nearly 20% in recent trade, up nearly $2 a share. That's put shares of the quantum-computing ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

U.S. stocks were again struggling with a bout of "bad breadth" on Thursday. All 11 S&P 500 sectors traded in the red in early going, although health-care and energy stocks wavered between gains and ...

PORTLAND, Ore. — An Oregon house cat died after eating pet food that tested positive for bird flu, Oregon authorities said, prompting a recall of raw frozen pet food that was sold nationwide.

U.S. stocks opened lower on Thursday as the market reopened following the Christmas holiday. Here is where stocks stood shortly after the opening bell: The S&P 500 was off by 13 points, or 0.2%, at ...

Efforts to fuel AI's ravenous appetite for power have seen some big technology companies ink deals in the nuclear sector this year -- Alphabet's Google, Amazon and Microsoft. Developers of small ...

TScan Therapeutics shares jumped 23% in premarket trading after a $30 million registered direct offering. Shares were trading around $3.58. The stock is down about 50% on the year.

Shares of Assembly Biosciences advanced after the company reported encouraging results from a clinical trial of its treatment for the hepatitis B virus. The stock was up 5.2% at $15.49 in premarket ...